Concepedia

Author

M. Sextro

University of Cologne

Also Known As

M Sextro, M. Sextro, Michael Sextro

13

Publications

2.5K

Citations

11

H-Index

24

Concepts

All Affiliations

University of CologneMedizinische Hochschule Hannover
MS

About

M. Sextro is an author at University of Cologne specializing in medicine, cancer research, and hematology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

1.3K

2

Allergy

1

1

106

3

Cellular Therapies

1

1

1.1K

4

Clinical Immunology

1

1

106

5

Gastroenterology

1

1

11

M. Sextro

×

9

Publications

2.2K

Citations

9

H-Index

YearCitations

Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial

Norbert Schmitz, Beate Pfistner, M. Sextro,

The Lancet

2002

1.1K

Clinical Presentation, Course, and Prognostic Factors in Lymphocyte-Predominant Hodgkin's Disease and Lymphocyte-Rich Classical Hodgkin's Disease: Report From the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's Disease

Volker Diehl, M. Sextro, Jeremy Franklin,

Journal of Clinical Oncology

1999

364

European Task Force on Lymphoma project on lymphocyte predominance Hodgkin disease: histologic and immunohistologic analysis of submitted cases reveals 2 types of Hodgkin disease with a nodular growth pattern and abundant lymphocytes.

Ioannis Anagnostopoulos, Martin‐Leo Hansmann, Kaarle Franssila,

PubMed

2000

282

BEACOPP, a new dose-escalated and accelerated regimen, is at least as effective as COPP/ABVD in patients with advanced-stage Hodgkin's lymphoma: interim report from a trial of the German Hodgkin's Lymphoma Study Group.

Volker Diehl, Jeremy Franklin, Dirk Hasenclever,

Journal of Clinical Oncology

1998

194

Poor clinical outcome of patients with Hodgkin's Disease and elevated interleukin-10 serum levels

Heribert Bohlen, Marcus M. Kessler, M. Sextro,

Annals of Hematology

2000

106

Lymphocyte-predominant Hodgkin's disease. An immunohistochemical analysis of 208 reviewed Hodgkin's disease cases from the German Hodgkin Study Group.

R von Wasielewski, Martin Werner, R. Fischer,

PubMed

1997

69

Safety of AlloPBPCT donors: biometrical considerations on monitoring long term risks.

Dirk Hasenclever, M. Sextro

PubMed

1996

47

Dose escalation of cytotoxic drugs using haematopoietic growth factors: A randomized trial to determine the magnitude of increase provided by GM-CSF

Michael Pfreundschuh, Dirk Hasenclever, Markus Loeffler,

Annals of Oncology

2001

16

How to restrict liver biopsy to high-risk patients in early-stage Hodgkin's disease

D. Lieberz, M. Sextro, U. Paulus,

Annals of Hematology

2000

11

Page 1